Magnetic Ventures — Full Portfolio

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

MSMatthew Stoudt(Co-Founder and CEO)inJSJosh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsENEntrada VenturesF-F-Prime CapitalJAJAZZ Venture PartnersPRPresence CapitalTETechstars

Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery.

AI & Machine LearningBiotechDeep TechToronto, CA

BFBrendan Frey(Chief Innovation Officer and Founder)inBOBrian O'Callaghan(Chief Executive Officer)inDJDavid Johnston(Chief Financial Officer)inCBClive Bertram(Chief Business Officer)inTMTom Masterson(Chief Operating Officer)inGHGreg Hoffman(Chief Scientific Officer)in

Co-investors1111.2 CapitalFUFuture VenturesKEKensington Capital Partners LimitedSOSoftBank Vision FundTRTrue VenturesBLBloomberg Beta

Eclipsebio provides RNA biology analytical services and sequencing-based assays that help drug developers and researchers characterize RNA at nucleotide-level resolution and generate datasets for AI-driven drug discovery.

AI & Machine LearningBiotechDeep TechSan Diego, US

EYEugene Yeo(Director)PCPeter Chu(Executive Officer, Director)inEric L Van Nostrand(Director)Hallie Kuhn(Director)

BoardEWEdmond Wong(Director)inDaniel Vasella(Director)

Co-investorsBRBrainstorm VenturesIGiGlobe PartnersPHPhoenix Venture Partners

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

JSJonathan Sporn(Founder)inAKAndrew Kruegel(Founder)inDSDalibor Sames(Founder)inJSJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)JSJonathan Sporn, M.D.(President and Chief Executive Officer)in

Co-investorsAEAera VCFRFrontera Technology VenturesFRFrontier Path VCJAJames Beshara FundJLJLSNONoetic+9 more

GroundGame.Health operates a technology platform and hyperlocal operating model that connects health plans, providers, employers, and community-based organizations to address barriers to care and social determinants of health.

Digital HealthHealthtechImpact & Social GoodSocialTampa, US

SRSusan Rawlings Molina(Executive Officer, Director, Promoter)inSridhar Akula(Executive Officer, Director)Aimee Dailey(Director)

BoardRGRobert Garber(Director)inShantanu Agrawal(Director)Jennifer Jarrell(Director)

Co-investors7W7wire VenturesCOCorewell Health VenturesRARaptor Group

HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.

BiotechMedical Devices

JAJulio Aguirre-Ghiso, Ph.D.(Co-Founder)

Co-investorsARARCH Venture PartnersRARaptor GroupHEHercules Capital, Inc.

Paradigm Health operates a platform that increases patient access to clinical trials through a provider-facing infrastructure combined with AI-powered research technology.

AI & Machine LearningHealthtechMedical DevicesSaaSColumbus, US

KTKent Thoelke(Founder and Chief Executive Officer)inJonathan Hirsch(Chief Strategy and Growth Officer)

Co-investorsARARCH Venture PartnersGEGeneral CatalystLULux CapitalF-F-Prime CapitalGVGV (Google Ventures)MUMubadala Capital

Prompt is an Ambient AI product and research company that develops human-centered AI products designed to sense the physical environment.

AI & Machine LearningConsumerDeep TechSan Francisco, US

TXTete Xiao(Founder)in

Co-investorsABAbstract VenturesAIAIX VenturesDCDCVC (Data Collective)NENeotribe VenturesBRBraidwellCDCDP Venture Capital+3 more

Proxima is a biotech company developing proximity therapeutics through a drug discovery engine and a structural proteomics data platform.

AI & Machine LearningBiotechDeep Tech

JBJonathan Bernardini(Founder)inZCZachary Carpenter(Co-founder & CEO)inLNLuca Naef(Co-founder & CTO)in

Co-investorsMOModi VenturesDCDCVC (Data Collective)

Proxima develops AI-powered gaming experiences and infrastructure, with a focus on embodied AI agents and applied AI systems for interactive entertainment.

AI & Machine LearningGamingSan Francisco, US

Ran Mo(Founder)in

Co-investorsKOKonvoy VenturesPRProgressionAIAIX VenturesALAlexandriaBABalderton CapitalBABayern Kapital+9 more

Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.

AI & Machine LearningBiotechDeep Tech

DRDavid Roblin(Chief Executive Officer)in

Co-investorsDCDCVC (Data Collective)HIHitachi VenturesRARaptor GroupNVNVentures

Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.

Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US

William S. Marth(Chief Executive Officer)

BoardRNRobert Nelsen

Co-investors8V8VCARARCH Venture PartnersCACatalio Capital Management, LPGVGV (Google Ventures)KOKoch Disruptive TechnologiesLULux Capital+5 more

Digital HealthHealthtechImpact & Social Good

Co-investors7W7wire VenturesCOCorewell Health VenturesRARaptor Group

HealthtechSan Francisco, US

ALEXANDER MARSON(Executive Officer, Director)PATRICK DAVID HSU(Director)JACOB CORN(Director)

BoardBBBLAKE BYERS(Director)in

Co-investorsGVGV (Google Ventures)

Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.

BiotechHealthtechCambridge, US

ARAaron Ring(Co-founder)inAMAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRGRoland Gendron(Chief Business Officer)inMZMichelle Zhang(Chief Scientific Officer)in

BoardVAVineeta Agarwala(Director)in

Co-investorsRARA CapitalANAndreessen HorowitzOMOMX VenturesAXAxial VCGVGV (Google Ventures)LOLoLa Capital Partners+1 more

Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.

AI & Machine LearningBiotechDeep TechCambridge, US

TKTuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)SCSamuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)

Co-investorsNONorthpond VenturesLILifeforce CapitalTATaiho Ventures, LLCDODolby Family Ventures

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.

BiotechDigital HealthHealthtech

VPVishal Patelin

Co-investorsATAtlas VentureBOBorealis VenturesBOBorealis VenturesOROrbiMedASAscenta CapitalFIFidelity Investments+3 more

Weave Bio offers an AI-native regulatory platform for preparing and managing eCTD-formatted regulatory dossiers, automating data organization, authoring, review, publishing and response management across the therapeutic lifecycle.

AI & Machine LearningBiotechSaaSSan Francisco, US

ACAri Caroline(Co-founder, Chief Strategy Officer)inBRBrandon Rice(Co-founder, Chief Executive Officer)in

Co-investorsFIFirsthandVCGRGround Up VenturesRARaptor GroupTMTMVUSUS Venture PartnersCHCharacter+1 more